IMPORTANCEAntenatal diagnosis of fetal weight is challenging, and the detection rate of fetal growth restriction (FGR) is low. Neonates with FGR are known to have an increased rate of obstetric intervention during labor, but the association of antenatal fetal weight estimation with mode of delivery and neonatal outcomes among neonates who are small and appropriate for gestational age (SGA and AGA) has not been reported. OBJECTIVE To evaluate the association of antenatal fetal weight estimation with mode of delivery and neonatal outcomes among neonates who are SGA and AGA, applying psychological concepts of cognitive bias and prospect theory to a model of clinical behavior. DESIGN, SETTING, AND PARTICIPANTS This cohort study was conducted between 2019 and 2020 using data from 2006 to 2018 at a tertiary care center in Jerusalem, Israel. Participants were 100 198 term singleton neonates without anomalies who were categorized into 4 groups according to the presence of an antenatal suspicion of FGR and final birth weight. Neonates with false positives (FPs;ie, group 1-FP: those with suspected FGR who were AGA) and neonates with true positives (TPs; ie, group 2-TP: those with suspected FGR who were SGA) were compared with neonates with AGA antenatal fetal weight estimation, including neonates with false negatives (FNs; ie, group 3-FN: those not suspected to have FGR who were SGA) and neonates with true negatives (TNs; ie, group 4-TN:those not suspected to have FGR who were AGA). Data were analyzed from July 2019 to July 2020. EXPOSURES Fetal weight estimation was performed according to sonographic and clinical evaluation at admission to labor, with FGR defined as a birth weight less than the 10th percentile for gestational age. Sonographic fetal weight estimation was performed according to Hadlock formula.Clinical weight estimation was performed by trained obstetricians. MAIN OUTCOMES AND MEASURESThe primary outcomes were obstetric intervention and mode of delivery; the secondary outcomes were neonatal Apgar score (with low Apgar score defined as <7) and neonatal intensive care unit (NICU) admission rates. RESULTS Among 100 198 neonates eligible for the study (50941 [50.8%] male neonates), there were 5671 neonates in group 1-FP, 3040 neonates in group 2-TP, 8508 neonates in group 3-FN, and 82 979 neonates in group 4-TN. Mean (SD) maternal age was 28.6 (5.7) years. Among 8711 neonates with suspected FGR, 34.9% were below the 10th percentile at birth, while 65.1% were AGA.Neonates with suspected FGR had a significantly increased rate of induction of labor (group 1-FP: 649 neonates [11.4%] and group 2-TP: 969 neonates [31.9%]) compared with neonates in group 3-FN (1055 neonates [12.4%]) and group 4-TN (7136 neonates [8.6%]) (P < .001) and a significantly increased rate of cesarean delivery (group 1-FP: 915 neonates [16.1%] and group 2-TP: 556 neonates [18.3%] vs group 3-FN: 1106 neonates [13.0%] and group 4-TN: 6588 neonates [7.9%]; P < .001).Increased NICU admission was found for neonates who were SGA compared with neona...
Current social trends of delayed reproduction to the fourth and fifth decade of life call for a better understanding of reproductive aging. Demographic studies correlated late reproduction with general health and longevity. Telomeres, the protective ends of eukaryotic chromosomes, were implicated in various aging-associated pathologies and longevity. To examine whether telomeres are also associated with reproductive aging, we measured by Southern analysis the terminal restriction fragments (TRF) in leukocytes of women delivering a healthy infant following a spontaneous pregnancy at 43–48 years of age. We compared them to age-matched previously fertile women who failed to conceive above age 41. The average TRF length in the extended fertility group (9350 bp) was significantly longer than in the normal fertility group (8850 bp; p-value = 0.03). Strikingly, excluding women with nine or more children increased the difference between the groups to over 1000 bp (9920 and 8880 bp; p-value = 0.0009). Nevertheless, we observed no apparent effects of pregnancy, delivery, or parity on telomere length. We propose that longer leukocyte telomere length reflects higher oocyte quality, which can compensate for other limiting physiological and behavioral factors and enable successful reproduction. Leukocyte telomere length should be further explored as a novel biomarker of oocyte quality for assessing reproductive potential and integrating family planning with demanding women’s careers.
The antenatal diagnosis of fetal weight is a challenge that relies on sonographic estimations and the clinical assessment of fetal and maternal status. Meanwhile, the rate of detection of fetal growth restriction (FGR) is <40%. Because neonates who are small for gestational age (SGA) are more likely to experience perinatal and long-term complications, the timely detection of FGR is important to prevent intrauterine death or long-term disability. In addition, approximately 30% of fetuses with FGR are born via cesarean delivery (CD). Yet, for fetuses with FGR, the benefit of CD and, alternatively, the optimal mode of delivery remain unclear. Given that fetal weight is unknown until after delivery, clinical decisions on the mode of delivery may be made based on the prospect theory or making decisions under stress with uncertain outcomes while subject to cognitive biases such as confirmation bias. The aim of this study was to examine biases associated with estimating fetal weight by evaluating the mode of delivery and outcomes for SGA and appropriate for gestational age (AGA) neonates.This study was conducted at a tertiary center in Jerusalem, Israel, from January 1, 2006, to December 31, 2018, using retrospective, deidentified data from electronic medical records. Included were neonates born to women with singleton, term pregnancies with no anomalies. They were categorized into 4 groups according to suspected FGR and actual birth weight. Neonates with suspected FGR were divided into 2 groups: those born AGA (false positive [1-FP]) and those born SGA [true positive [2-TP]). They were compared with neonates not suspected of FGR: those born SGA (false negative [3-FN]) and those born AGA (true negative [4-TN]). The primary outcomes were obstetric intervention and mode of delivery. Secondary outcomes were neonatal Apgar score <7 minutes and admission to the neonatal intensive care unit (NICU).A total of 100,198 neonates were included in the analysis, with 5671 in the 1-FP group, 3040 in the 2-TP group, 8505 in the 3-FN group, and 82,979 in the 4-TN group. Neonates with suspected FGR (1-FP and 2-TP groups) compared with those without suspected FGR (3-FN and 4-TN groups) were more likely to have been induced (11.4% and 31.9% vs 12.4% and 8.6%; P < 0.001), delivered by elective CD (12% and 9.5% vs 5.9% and 4.6%; P < 0.001), and delivered by CD overall (16.1% and 18.3% vs 13% and 7.9%; P < 0.001). Small for gestational age neonates (2-TP and 3-FN groups) compared with AGA neonates (1-FP and 4-TN groups) had significantly higher rates of instrumental delivery (7.9% and 8.6% vs 4.4% and 5.5%; P < 0.001), third-stage placental complications (3.4% and 3.5% vs 2.6% and 2.8%; P < 0.001), maternal hemoglobin drop >3 g/dL (6.2% and 7.0% vs 5.4% and 5.9%; P < 0.001), and maternal blood transfusions (1.2% and 1.1% vs 0.9% and 0.8%; P < 0.001). In multivariate analysis, suspicion of FGR was independently associated with an increase in the rate of CD >70% (odds ratio, 1.72; 95% confidence interval, 1.56-1.88; P < 0.001).Of the 8711 neon...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.